JOHN MARAGANORE - 20 May 2021 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Director
Signature
/s/ William Cook, as Attorney-in-fact for John Maraganore
Issuer symbol
AGIO
Transactions as of
20 May 2021
Transactions value $
$0
Form type
4
Filing time
24 May 2021, 16:45:46 UTC
Previous filing
17 May 2021
Next filing
02 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Restricted stock unit Award $0 +1,585 $0 1,585 20 May 2021 Common stock 1,585 Direct F1, F2
transaction AGIO Stock options (right to buy) Award $0 +8,888 $0 8,888 20 May 2021 Common stock 8,888 $56.76 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2 The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested
F3 This option was granted on May 20, 2021. The shares underlying this option vest as to 100% of the underlying shares on May 20, 2022.